Global Leading Market Research Publisher QYResearch announces the release of its latest report “Central Water Purification System – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Central Water Purification System market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Central Water Purification System was estimated to be worth US428millionin2025andisprojectedtoreachUS428millionin2025andisprojectedtoreachUS 669 million, growing at a CAGR of 6.7% from 2026 to 2032. In 2024, global Water Purification System production reached approximately 11,230 units with an average global market price of around US$38,100 per unit.
For laboratory managers, hospital facility directors, and pharmaceutical plant engineers, the core water quality challenge is precise: producing and distributing consistent high-purity water (resistivity 18.2 MΩ·cm, TOC <5 ppb, bacteria <1 CFU/mL, endotoxins <0.25 EU/mL for clinical applications) to multiple end-use points (sinks, autoclaves, glassware washers, analyzers, clinical analyzers, humidifiers, cooling loops) throughout a facility, with automated quality monitoring (in-line resistivity, TOC, conductivity, temperature), recirculating loop to prevent stagnation (biofilm), and centralized host (pretreatment, reverse osmosis (RO), electrodeionization (EDI), ion exchange (IX), ultraviolet (UV) oxidation (185 nm for TOC reduction, 254 nm for disinfection), ultrafiltration (UF) end-polishing). The solution lies in central water purification systems—skid-mounted or standalone units feeding a recirculating pipe loop (ring main) with multiple point-of-use (POU) valves. Unlike point-of-use (POU) purifiers (individual units at each sink, inconsistent quality, higher maintenance, consumables per unit), central systems offer lower total cost of ownership (TCO) for >6-10 outlets, consistent water quality, and centralized consumables replacement (RO membranes, ion exchange resins, UV lamps, filters). As pharmaceutical (GMP, USP <645>) and clinical laboratory (ISO 15189) standards tighten, the central water purification market grows.
The Central Water Purification System is an integrated framework that achieves water purification through a centralized host, which combines multiple technological processes such as pretreatment, reverse osmosis,ion exchange, ultraviolet oxidation, ultrafiltration, and microfiltration, equipped with a storage tank and a circulatingpipeline network. This setup efficiently generates high-purity water from a single source and uniformly distributes it to multiple end-use points via the pipeline network. The centralized design ensures unified management and standardized operation of the water treatment process, eliminating the need for redundant equipment and resource waste associated with decentralized systems. It also allows for flexible adjustment of output water quality parameters to meet varying demands, achieving full closed-loop control from pressurized water intake to terminal supply, thereby maintaining consistent and stable water quality. Additionally, the system incorporates advanced monitoring modules, such as PLC control and automatic alarms, enabling real-time detection and optimization of operational status, reducing the need for manual intervention, and supporting future upgrades through modular expansion, further enhancing overall operational efficiency and reliability.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6097628/central-water-purification-system
1. Industry Segmentation by Configuration and Application
The Central Water Purification System market is segmented as below by Type:
- Mobile – 28% market share (2025). Wheeled, compact (pumped, hospital wards, temporary lab). Smaller flow rate (20-200 L/h). Lower cost (15-30% less than stationary).
- Stand-alone – 72% market share. Skid mounted, room installation. Higher flow (100-2,000 L/h). PLC control, data logging, remote monitoring. Heavy industry.
By Application – Laboratory (research, analytical, clinical chemistry, university, biotech) leads with 48% market share. Medical (hospitals, clinics, dialysis water for hemodialysis equipment) 28% share. Industrial (pharma production (water for injection, WFI), electronics (semiconductor), cosmetics, food) 18% share. Other (educational, power plant) 6% share.
Key Players – Global water purification: Sartorius (Germany, Arium systems), Merck (Milli-Q® central systems), Xylem (PureLab), Veolia (ELGA, LabWater). Avidity Science (US, E-pure, central). Shanghai Hitech Instruments (China), Xiamen RSJ Water Purification Technology (China), Sichuan ULUPURE Ultra Pure Technology (China), Shanghai Tauto Biotech (China). Labware Group (Hong Kong), Shanghai HyperpureX, Qingdao PROSEERS Technology.
2. Technical Challenges: Biofilm Control, Resistivity, and TOC
Recirculating loop design — Pipe loop must maintain turbulent flow (velocity >1.5 m/s) to prevent biofilm growth. Sanitary fittings (tri-clamp), low dead legs (<3× diameter), periodic hot water sanitization (80°C) or ozone injection. Material: stainless steel (316L) or PVDF plastic (polytetrafluoroethylene (PTFE) for low TOC). POU valves zero dead leg.
Consistent resistivity (18.2 MΩ·cm) — Mixed-bed ion exchange (IX) final polishing. Deionization (DI) cartridges (mixed bed resin) or continuous electrodeionization (CEDI). Resistivity monitor (precision 0.01 MΩ·cm). Alarm if drops below 5-10 MΩ·cm.
TOC (Total Organic Carbon) reduction — UV oxidation (185 nm) produces hydroxyl radicals that oxidize organic compounds. UV intensity monitor, quartz sleeve cleaning (annual). Target TOC <5 ppb. Non-UV path TOC higher.
3. Policy, User Cases & Industry Standards (Last 6 Months, 2025-2026)
- USP <645> Water Conductivity (2026 revision) – Tightened conductivity limits for purified water (PW) and water for injection (WFI). Central systems must meet.
- ISO 15189:2025 (Medical laboratories) – Requires documented water quality (resistivity, bacteria, endotoxins). Central water system with logging.
- China GB/T 6682-2025 (Analytical laboratory water specification) (effective April 2026) – Grade 1 water (18.2 MΩ·cm, TOC <20 ppb). Central purification required.
User Case – Hospital Lab (clinical chemistry) — Central system (Merck Millipore) with loop supplying 15 outlets in pathology, hematology, biochemistry labs. Resistivity displayed at each POU (digital readout). Annual bacteriogical testing (heterotrophic plate count, <100 CFU/mL).
User Case – Pharmaceutical QC lab — Central water system (Sartorius Arium) with 200L/h RO/EDI/UV/UF. Loop of PVDF (2 inch, 50m). Weekly sanitization (hot water 80°C). Conductivity data logged for GMP audit.
4. Exclusive Observation: Remote Monitoring & Predictive Maintenance
Central water systems include PLC with remote access (Modbus TCP, Ethernet, OPC UA). Cloud dashboard shows resistivity, TOC, flow rate, UV lamp life, resin depletion, pressure, temperature. Predictive resin/filter change alerts. Data export for compliance. Veolia (ELGA), Merck (Milli-Q) offer cloud portal subscription.
5. Outlook & Strategic Implications (2026-2032)
Through 2032, the central water purification system market will segment: stand-alone (25-2000 L/h, lab/hospital) — 65% value, 5-6% CAGR; mobile (20-200 L/h, temporary) — 25% value, 4-5% CAGR; high-purity (18.2 MΩ·cm, TOC <2 ppb) semiconductor grade — 10% value, 6-7% CAGR. Key success factors: resistivity (18.2 MΩ·cm), TOC (<5 ppb), loop design (velocity, dead leg, material), and remote monitoring. Suppliers who fail to transition from point-of-use to centralized systems — and who cannot provide validated sanitary loop design — will lose lab and pharma high-purity water market share.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
